The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis

The Journal of Urology
A J MarianiA Moriera

Abstract

Between March 1976 and June 1985, 1,000 consecutive adults with asymptomatic gross or microscopic hematuria in the absence of proteinuria were evaluated urologically. Lesions that could account for the hematuria were detected in 88.3 per cent of the patients. Life-threatening lesions were diagnosed in 9.1 per cent of the patients, while lesions requiring at least observation were present in 22.8 per cent. The incidence of life-threatening lesions increased with age, with a sharp increase after age 50 years. Life-threatening lesions were more common in men (13.6 per cent) than in women (4.9 per cent). In general, as the degree of hematuria increased so did the yield of life-threatening lesions; however, there was no "safe" lower limit of hematuria. Of the patients with life-threatening lesions 18.6 per cent had at least 1 urinalysis with less than 3 red blood cells per high power field within 6 months of the diagnosis. The direct medical cost of a hematuria evaluation was $777. The difference in direct medical costs to diagnose and treat localized versus metastatic genitourinary cancer was $48,070 in 3 matched pairs of patients. In this study group 77 of 84 patients (92 per cent) diagnosed with genitourinary cancer had localized...Continue Reading

References

Oct 1, 1979·Journal of the American Geriatrics Society·S E Ziffren
Jan 30, 1978·JAMA : the Journal of the American Medical Association·S SternS Zedek
Jul 1, 1978·Annals of Internal Medicine·B E VanZeeJ R Jaenike
Apr 1, 1977·British Journal of Urology·N J Blacklock
May 1, 1987·The Journal of Urology·G A Schuster, G A Lewis
May 1, 1971·The Journal of Urology·E D Vaughan, A W Wyker
Jan 1, 1969·The Journal of Urology·S J Antolak, G T Mellinger
Sep 1, 1966·Journal of Clinical Pathology·D R Triger, J W Smith
Mar 1, 1983·Urology·J G Abuelo
Jul 1, 1984·The Journal of Urology·A J MarianiC V Hodges
Oct 1, 1984·The Journal of Urology·H N NoeS Roy
Aug 1, 1984·The Journal of Urology·S E KrausR J Krane
Nov 20, 1982·British Medical Journal·R G FassettK F Fairley
Nov 1, 1982·AJR. American Journal of Roentgenology·G W HartmanB Williamson
Jul 1, 1982·American Journal of Surgery·A G GreenburgG W Peskin
Oct 1, 1981·Urology·W C Carter, S N Rous
Sep 1, 1980·The Journal of Urology·A L Golin, R S Howard
May 1, 1980·Scandinavian Journal of Clinical and Laboratory Investigation·H KierkegaardP J Jørgensen
Jan 1, 1956·The Journal of Urology·E GARTMAN
Jun 16, 1956·Journal of the American Medical Association·L F GREENEE D HENDRICKS
Jun 14, 1958·Journal of the American Medical Association·E P ALYEA, H H PARISH
Jan 1, 1959·A.M.A. Archives of Internal Medicine·W T WRIGHT
Aug 26, 1961·British Medical Journal·B LYTTON
Jun 1, 1926·The Journal of Clinical Investigation·T Addis

❮ Previous
Next ❯

Citations

Dec 1, 1994·British Journal of Urology·C SparwasserR A Pust
Jul 1, 1995·The Journal of Urology·E M MessingJ D Wegenke
Feb 1, 1997·Postgraduate Medicine·J J McCarthy
Jan 1, 1997·International Urogynecology Journal and Pelvic Floor Dysfunction·H A Winkler, P K Sand
Aug 5, 2000·Current Opinion in Urology·W Hassen, M J Droller
Mar 2, 2002·BJU International·N M HarrisS A V Holmes
Jun 6, 2003·The New England Journal of Medicine·Robert A Cohen, Robert S Brown
Feb 4, 2005·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Muhammad Rafique, Abrar A Javed
Mar 12, 2009·Current Sports Medicine Reports·Joseph J Bernard
Dec 5, 2009·Clinical and Experimental Nephrology·UNKNOWN Japanese Society of Nephrology
Dec 17, 2009·BJU International·Hugh MostafidDerek Fawcett
Mar 3, 2011·Der Urologe. Ausg. A·P Hüppe, F Wawroschek
Sep 18, 2013·Emergency Medicine Journal : EMJ·Dominique C OlthofJ Carel Goslings
Oct 18, 2016·The Journal of Urology·Kim E M van KesselEllen C Zwarthoff
Jan 14, 2020·Bladder Cancer·Rashed GhandourYair Lotan
Mar 1, 1997·Postgraduate Medical Journal·A G RockallJ A Vale
Apr 11, 2000·Scandinavian Journal of Urology and Nephrology·Y SuzukiH Ohji
Jul 29, 2010·Cancer·Brent K HollenbeckDavid C Miller
May 25, 2012·AJR. American Journal of Roentgenology·Aart J van der Molen, Marina C Hovius
Aug 17, 2014·Der Urologe. Ausg. A·M HorstmannM O Grimm
Dec 10, 2013·Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes·Julien Rhéaume-LanoieAn Tang
May 27, 2014·The Journal of Urology·Yair LotanShahrokh F Shariat
Jan 24, 2015·AJR. American Journal of Roentgenology·Katherine M MullenStuart G Silverman
Dec 3, 2014·Journal of General Internal Medicine·Jeffrey C BassettDaniel A Barocas
Jan 1, 2013·Clinical Medicine Insights. Blood Disorders·Prashant Veerreddy
Sep 4, 2015·The Journal of Urology·Kim E M van KesselWim Van Criekinge
Jan 25, 2017·Expert Review of Anticancer Therapy·Petros SountoulidesLinda Metaxa
Jul 28, 2017·International Journal of Clinical Practice·Andreas EisenhardtJochen Heß
Sep 28, 2018·World Journal of Urology·Francesco SoriaShahrokh F Shariat
Mar 1, 1993·British Journal of Urology·J P Britton
Aug 18, 2005·BJU International·Murray S FeldsteinDonald E Novicki
May 24, 2005·AJR. American Journal of Roentgenology·Elaine M CaoiliJames E Montie
Jul 2, 2005·Journal of Endourology·Armen H DikranianAnne F Kosco
Mar 5, 2008·Journal of Endourology·Rizk El-GalleyPeter N Kolettis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.